Novartis and Monte Rosa's $5.7 Billion Bet on New Drugs
Update: 2025-09-15
Description
Novartis just dropped $5.7 billion on a deal with Monte Rosa Therapeutics, sending shockwaves through the pharmaceutical world! This massive collaboration aims to develop groundbreaking drugs for immune diseases, marking a huge win for both companies and a leap forward for innovative treatments. Find out how this deal could revolutionize patient care and what it means for the future of medicine.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
